MTB reporter: Standardized reporting of tumoroid drug screening to guide Molecular Tumor Board treament decisions

• Unité de recherche: INNOSUISSE
• Numéro de projet: 121.649 IP-LS
• Titre du projet anglais: MTB reporter: Standardized reporting of tumoroid drug screening to guide Molecular Tumor Board treament decisions

Mots-clé (Anglais)

Life sciences, Personalised medicine

Résumé des résultats (Abstract) (Anglais)

The aging population creates a costly medical burden. Cancer is a complex disease and requires personalized treatments, as single agents often fail. Using a patient?s cells, we can test treatment efficacy, reducing exposure to toxic, expensive, and inefficient therapies, benefiting society overall.